home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Regulatory Affairs Part I: The IND Phase

 
  February 08, 2012  
     
 
DIA, Horsham, PA USA
Apr 11 2012 8:30AM - Apr 13 2012 12:15PM


Learn about FDA regulations and expectations for the content, submission, and review of INDs and the importance of regulatory strategy.

 

What you will learn

·          The fundamentals of the Investigational New Drug Products

o    Preparation

o    Content

o    Strategy

·          Meetings and other interactions with FDA

 

This blended learning opportunity features two archived online courses focusing on fundamental concepts followed by a training course consisting of interactive lectures and hands-on workshops.

Archived Online Course Component

Introduction to Regulation of Drugs and Biologics in the United States

Learn about FDA history, regulations, roles and responsibilities and organization relative to the development of drugs and biologics in the US.

What you will learn

·          Historical perspectives of drug and biologic regulation

·          Key legislative milestones and impact on product development

·          Overview of the organization, roles and responsibilities of FDA

·          Key regulatory definitions

 

Overview of the Development Process for New Drugs and Biologics

Learn the processes characteristic of drug and biologic product discovery, development and commercialization in the US.

What you will learn

·          Three Stages:  Discovery, Development and Commercialization of New Drugs and Biologics

·          Overview of Chemistry Manufacturing and Controls processes

·          Highlights of Nonclinical studies

·          Description and definition of Clinical Phases of study

·          Expectations after the approval of new products

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association.  Speakers, agenda and CE information are subject to change without notice.  Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

Event Code:
12429
 
 
Organized by: DIA
Invited Speakers: Cynthia L. Kirk, PhD
President
CKL Regulatory Solutions, United States
 
Deadline for Abstracts: Call contact
 
Registration:
For registration questions, please contact Elizabeth Espich  at +1-215-293-5802 or Elizabeth.espich@diahome.org 
For agenda details, please contact Susan Berkelbach at +1-215-442-6183 or Susan.Berkelbach@diahome.org

E-mail: susan.berkelbach@diahome.org
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.